Dominique Dufayet

Title: Innovations by Dominique Dufayet

Introduction

Dominique Dufayet is an accomplished inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the area of insulin gene expression in pancreas cells. With a total of two patents to her name, her work has the potential to impact diabetes treatment and research.

Latest Patents

Dufayet's latest patents include methods for inducing beta cell differentiation in human cells by stimulating the GLP-1 receptor. The first patent provides methods for inducing insulin gene expression in cultured pancreas cells. This method involves contacting a culture of endocrine pancreas cells expressing a PDX-1 gene with a GLP-1 receptor agonist. The cells are cultured under conditions that allow them to be in contact with other cells, thereby inducing insulin gene expression. The invention also includes high throughput screening methods for modulators of β-cell function, stable cultures of cells made by these methods, and methods for treating human subjects using these techniques. The second patent similarly focuses on inducing insulin gene expression in pancreas cells expressing recombinant PDX-1, utilizing the same GLP-1 receptor agonist approach.

Career Highlights

Dufayet is affiliated with the University of California, where she continues her research and innovation in the field of biotechnology. Her work is recognized for its potential to advance the understanding and treatment of diabetes.

Collaborations

Dufayet collaborates with Fred Levine, a fellow researcher, to further explore the implications of her inventions in the medical field.

Conclusion

Dominique Dufayet's innovative work in inducing insulin gene expression in pancreas cells represents a significant advancement in diabetes research. Her contributions have the potential to lead to new treatments and improve the quality of life for individuals with diabetes.